Systematic review / meta-analysis / 2018
Psyllium fiber supplementation significantly reduces LDL cholesterol, non-HDL cholesterol, and apolipoprotein B.
A systematic review and meta-analysis of 28 randomized controlled trials evaluated the effects of psyllium fiber (duration ≥3 weeks) on blood lipids in 1,924 participants. Supplementation with a median dose of ~10.2 g psyllium significantly lowered LDL cholesterol (MD = -0.33 mmol/L; 95% CI: -0.38, -0.27 mmol/L; P < 0.00001), non-HDL cholesterol (MD = -0.39 mmol/L; 95% CI: -0.50, -0.27 mmol/L; P < 0.00001), and apoB (MD = -0.05 g/L; 95% CI: -0.08, -0.03 g/L; P < 0.0001). Evidence quality assessed via GRADE was rated moderate for LDL and non-HDL cholesterol due to inconsistency, and high for apoB.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 1,924 individuals with or without hypercholesterolemia across 28 trials
- What was measured
- LDL cholesterol, non-HDL cholesterol, and apolipoprotein B
THE PAPER
Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials.
Jovanovski E, Yashpal S, Komishon A, Zurbau A, Blanco Mejia S, Ho HVT, Li D, Sievenpiper J, Duvnjak L, Vuksan V. Am J Clin Nutr, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.